助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   拉米夫定 在 感染性疾病及传染病 分类中 的翻译结果: 查询用时:1.387秒
图标索引 在分类学科中查询
所有学科
感染性疾病及传染病
消化系统疾病
药学
外科学
临床医学
基础医学
生物学
肿瘤学
中医学
更多类别查询

图标索引 历史查询
 

拉米夫定     
相关语句
  lamivudine
    1. The Experimental Study of rALR on Immunologic Response Induced by Exogenous Antigen in Rat 2. Analysis on Cause of Death in 115 Patients with Hepatic Failure Induced by Viral Hepatitis 3. The Primary Clinical Study of Peginterferon Alfa-2a in the Treatment the Patients with HBeAg-Positive Chronic Hepatitis B and with Drug Fast to Lamivudine
    1.肝再生增强因子对外原性抗原引起机体免疫应答影响的初步研究 2.病毒性肝炎肝衰竭患者死亡原因分析 3.聚乙二醇化干扰素α-2a治疗HBeAg阳性的慢性乙型肝炎及其应用于拉米夫定耐药的初步临床观察
短句来源
    1.Clinic Study on the Adefovir Dipivoxil Treat Patients with HBeAg(+) Hepatitis B Resistant to Lamivudine 2.Preliminary Study on the Effect of Severe Hepatitis Plasma on Umbilical Cord Blood Mesenchymal Stem Cells in Vitro
    1.阿德福韦酯治疗拉米夫定耐药HBeAg(+)慢性乙肝的临床研究 2.重型肝炎患者血浆对体外培养脐血间充质干细胞影响的初步研究
短句来源
    However,22.8% of patients in the control group had YMDD variant HBV as compared with 3.03% in the treated group,and P value was <0.05.Conclusion:Thymosin-α1 combined with Lamivudine is effective for the patients with chronic hepatitis B and is valuable to be used in clinical.
    HBV YMDD变异株:治疗组仅有1例(3.03%),对照组有8例(22.8%),两组比较,差异有统计学意义(P<0.05)。 结论:拉米夫定联合胸腺肽α1治疗慢性乙型肝炎疗效较好,值得临床应用。
短句来源
    METHODS 360 patients with lamivudine was measured by gene-chip,ELISA and autobiological analyzer.
    方法利用基因芯片、ELISA及生化检测技术检测360例慢性乙肝患者服用拉米夫定4~24个月后YMDD变异、HBV-DNA及ALT水平变化。
短句来源
    The dosage in the entecavir group and lamivudine group was 0.5 mg/d and 100 mg/d, respectively, and the duration of therapy was 48~96 weeks.
    恩替卡韦组与拉米夫定组的剂量分别为0.5mg/d和100mg/d。 疗程为48~96周。
短句来源
更多       
  lamivudine therapy
    [Objective] To explore the relationship between YMDD motif mutation, hepatitis B viral loads and alanine aminotransferase (ALT) levels during Lamivudine therapy for chronic hepatitis B. [Methods] 140 chronic hepatitis B patients receiving 48~96 weeks Lamivudine therapy were studied.
    目的探讨拉米夫定治疗慢性乙型肝炎引起的HBVYMDD变异与HBVDNA病毒载量与血清谷丙转氨酶(ALT)之间的关系。 方法140例拉米夫定治疗48 ̄96周的慢性乙型肝炎患者为研究对象。
短句来源
    Preliminary trial of lamivudine therapy for chronic HBV infection
    拉米夫定治疗慢性乙型肝炎病毒感染的近期疗效
短句来源
    Advance on Lamivudine Therapy for Chronic Hepatitis B
    拉米夫定治疗慢性乙型肝炎的进展
短句来源
    Early Hepatitis B e Antigen Seroconversion after Lamivudine Therapy in Patients with Chronic Hepatitis B
    慢性乙型肝炎拉米夫定治疗后的HBeAg早期血清转换
短句来源
    Clinical observation of lamivudine therapy in 50 patients with chronic hepatitis B infection
    拉米夫定治疗50例慢性乙型肝炎患者自身前后对照试验
短句来源
更多       
  lamivudine treatment
    Objective To investigate changes in serum IFN-γand IL-4 levels of patients with chronic hepatitis B during lamivudine treatment.
    目的观察拉米夫定治疗慢性乙型肝炎过程中血清γ-干扰素(IFN-γ)、白细胞介素4(IL-4)等细胞因子的动态变化。
短句来源
    OBSERVING THE CLINICAL EFFECT OF LAMIVUDINE TREATMENT IN 32 CASES OF CHRONIC HEPATITIS B
    拉米夫定治疗32例慢性乙型肝炎的临床疗效观察
短句来源
    Influence of HBV mutation during lamivudine treatment on clinical prognosis of chronic hepatitis B
    拉米夫定相关性HBV变异对乙型肝炎预后的影响
短句来源
    Th_1/Th_2-type Cytokines Produced by PBMC in Chronic Hepatitis B Patients during Lamivudine Treatment
    拉米夫定治疗慢性乙型肝炎过程中外周血单核细胞产生Th_1/Th_2类细胞因子的动态观察
短句来源
    Preliminary efficacy of lamivudine treatment in patients with hepatitis Be antigen negative chronic HBV infection
    拉米夫定治疗HBeAg阴性的慢性HBV感染近期临床观察
短句来源
更多       
  using lamivudine
    Clinical Observation of Treating Patient With Chronic Hepatitis B Using Lamivudine Combined With Marine Injection
    拉米夫定联合博尔泰力治疗慢性乙型肝炎临床研究
短句来源
    Efficacy of treating chronic hepatitis B using lamivudine combining with thymosin α_1
    拉米夫定联合胸腺肽α_1治疗慢性乙型肝炎疗效观察
短句来源
    Relationship between the Antiviral Effect and Changes in Helper T(Th) Cytokine Levels in the Treatment of Chronic Hepatitis B Using Lamivudine Combined with Alpha Interferon
    拉米夫定联合干扰素治疗慢性乙型肝炎的抗病毒疗效与Th细胞因子变化的关系
短句来源
    but there was no significant difference between the rate of HBV YMDD mutations in the not using lamivudine group and the combination treatment group(x2=2.35, P>0.05).
    而未用拉米夫定组与联用拉米夫定/干扰素组的HBV-YMDD变异发生率无显著性差异(x2=2.35,P>0.05)。
短句来源
    Conclusion Treating chronic hepatitis B using lamivudine combining with thymosin α 1 has a coordinated effect.
    结论 拉米夫定与胸腺肽α1 联合应用治疗慢性乙型肝炎的确具有协同作用 ,明显优于单用拉米夫定治疗慢性乙型肝炎
短句来源
更多       

 

查询“拉米夫定”译词为其他词的双语例句

 

查询“拉米夫定”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  lamivudine
Rapid titrimetric and spectrophotometric assay methods for the determination of lamivudine in pharmaceuticals using iodate and t
      
In titrimetry, an aqueous solution of lamivudine is titrated directly with iodate in an acidic medium, and in the presence of an excess of bromide using methyl orange as an indicator.
      
In all methods, the amount of iodate which reacted corresponds to the amount of lamivudine content.
      
The methods were successfully applied to the assay of lamivudine in tablet form and the results were compared with those of a reference method by applying the Student's t-test and F-test.
      
Disease progression to AIDS was associated with ?4 and ?2, most evident for zidovudine-lamivudine regimens without a protease inhibitor (P = 0.03); and, 3.
      
更多          
  lamivudine therapy
Clinical features of chronic hepatitis B patients with YMDD mutation after lamivudine therapy
      
Objective: To study the clinical features of chronic hepatitis B (CHB) patients with tyrosine-methionine-aspartate-aspartate (YMDD) mutation after lamivudine therapy.
      
Methods: This investigation was a retrospective study of 63 CHB patients with YMDD mutation during lamivudine therapy.
      
Results: YMDD mutation occurred 7:_44 months (median, 21.5 months) after the start of lamivudine therapy.
      
This subset of patients might have benefited from the continued lamivudine therapy.
      
更多          
  lamivudine treatment
As several studies on the use of lamivudine for hepatitis B show, the development of resistance in the viral polymerase under lamivudine treatment, however, causes a significant clinical problem.
      
After successful combined kidney/liver transplantation the patient became HBsAg and HBV DNA (detected by PCR) negative under continuous hyperimmune globulin and lamivudine treatment.
      
Lamivudine treatment (100?mg/day) was started and clearance of HBsAg was documented 1 year later.
      
Lamivudine treatment (100?mg daily) resulted in rapid loss of hepatitis B virus DNA, resolution of hepatitis, and clinical recovery.
      
Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with n
      
更多          
  using lamivudine
New treatments using lamivudine and other nucleoside analogues such as famciclovir, lobucavir, and adfovir showed promising results although sustained suppression of viral replication is unusual after discontinuation of therapy.
      
Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature
      
  其他


点击这里查询相关文摘
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关拉米夫定的内容
在知识搜索中查有关拉米夫定的内容
在数字搜索中查有关拉米夫定的内容
在概念知识元中查有关拉米夫定的内容
在学术趋势中查有关拉米夫定的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社